Eric Lefebvre - 25 Jan 2023 Form 4 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Role
Chief Medical Officer
Signature
/s/ Mike Ouimette, attorney-in-fact
Issuer symbol
PLRX
Transactions as of
25 Jan 2023
Transactions value $
$0
Form type
4
Filing time
27 Jan 2023, 18:15:26 UTC
Previous filing
25 Jan 2023
Next filing
31 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLRX Common Stock Award $0 +57K +74.1% $0.00 134K 25 Jan 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLRX Stock Option (right to buy) Award $0 +80K $0.00 80K 25 Jan 2023 Common Stock 80K $34.65 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These are restricted stock units that vest in three equal annual installments beginning January 16, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date.
F2 1/48th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of January 1, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date.